Jun 24, 2011

Plexus Ventures Successfully Concludes Product Divestment Assignment

Los Angeles, California — Plexus Ventures is pleased to announce the successful completion of its most recent divestment project. Plexus provided professional services to Novartis Consumer Health in the divestiture of an OTC product having European sales to a regionally strong European company.

About Plexus Ventures

Plexus Ventures has earned the title Business Builders in Healthcare over nearly three decades as a leading corporate and business development consultancy for healthcare industry companies. Plexus assists clients of all sizes and capabilities to achieve their strategic business development objectives. Plexus industry professionals are conveniently located in the United States, Europe and Asia-Pacific markets, enabling Plexus to benefit its clients with both local knowledge and global reach.

Trending Now

News

Plexus Ventures Celebrates 20 Years in Japan

Jul 14, 2026

Tokyo, Japan – Plexus Ventures is proud to celebrate the 20th anniversary of our Tokyo Office in 2026 — two decades of dedicated service to Japanese pharmaceutical, biotechnology, consumer health, and medical device companies. A Foundation Built on Experience The...

Plexus Ventures Assists First Pharma in Successful Completion of Business Sale to a Strategic Buyer

Apr 17, 2024

Philadelphia, Pennsylvania – First Pharma (“First Pharma”), a private Australian pharmaceutical company operating in the consumer healthcare (“CHC”) segment, has successfully completed the sale of its business to a strategic buyer. First Pharma’s portfolio of products...

Plexus Ventures Assists Sanofi Consumer Health to Divest a Product Portfolio in Australia and South-East Asia to Phoenix Labs

May 5, 2023

Philadelphia, Pennsylvania – Phoenix Labs (“Phoenix”) has acquired a portfolio of well-established consumer health products from Sanofi Consumer Health (“Sanofi”). The portfolio includes Proctosedyl™, the leading pharmacy-only haemorrhoid treatment in Australia and a...